MPN Watch

Dossier clinicaltrials observational 01-oct-2026

Phenotypic and Functional Characterization of Bone Marrow Macrophages in Chronic Myelomonocytic Leukemia

Key claim: The MAC-AGE study will phenotypically, transcriptionally, and functionally compare bone marrow macrophages in CMML with age-matched controls to define CMML-associated macrophage alterations and candidate therapeutic targets in the marrow immune microenvironment.

Abstract

MAC-AGE is a single-center study designed to characterize bone marrow macrophages in patients with chronic myelomonocytic leukemia (CMML) and to compare them with macrophages from age-matched controls undergoing elective total hip arthroplasty. Phenotypic, transcriptional and functional analyses will be performed using spectral/multiparametric flow cytometry, single-cell RNA sequencing and ex vivo functional assays. The study aims to identify CMML-associated macrophage alterations and potential therapeutic targets within the bone marrow immune microenvironment.

Why this matters

The MAC-AGE study will phenotypically, transcriptionally, and functionally compare bone marrow macrophages in CMML with age-matched controls to define CMML-associated macrophage alterations and candidate therapeutic targets in the marrow immune microenvironment.

Source

Link

Briefing card

Phenotypic and Functional Characterization of Bone Marrow Macrophages in Chronic Myelomonocytic Leukemia
Stage: observational · clinicaltrials · 01-oct-2026

The MAC-AGE study will phenotypically, transcriptionally, and functionally compare bone marrow macrophages in CMML with age-matched controls to define CMML-associated macrophage alterations and candidate therapeutic targets in the marrow immune microenvironment.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07852494

Ask about this finding

Replies are grounded in the abstract and metadata above. The model will quote directly when possible and say so if a question isn't covered.

build build 612 · 69ce4cf-dirty · 2026-11-11